OZABIO delivered an outstanding presence at Vitafoods India 2026, marking one of our most successful exhibitions to date. The event proved to be a powerful platform for high-value networking opportunities, strategic collaborations, and industry recognition.
A key highlight of our participation was the feature of our Liposomal Berberine in the New Innovation Zone-a prestigious space dedicated to groundbreaking advancements in nutraceutical science. This recognition reinforced OZABIO’s position at the forefront of next-generation ingredient development and delivery technologies.
Vitafoods India 2026 brought an overwhelming response for OZABIO, enabling us to:
● Establish numerous high-quality connections with industry leaders and global buyers
● Engage with brands actively seeking advanced, high-bioavailability solutions
● Showcase the real-world impact of our LIPOZA liposomal platform
● Initiate promising discussions for future collaborations and product development
The strong interest in our innovations—especially Liposomal Berberine—validated the growing demand for science-backed, performance-driven ingredients.
Being featured in the New Innovation Zone is a testament to OZABIO’s commitment to pushing boundaries in formulation science. Our Liposomal Berberine stood out for its enhanced absorption, improved efficacy, and superior formulation potential, attracting significant attention from both technical experts and commercial stakeholders.
Our success at Vitafoods India 2026 reflects OZABIO’s mission to lead with innovation, build meaningful partnerships, and deliver high-impact nutraceutical solutions. We look forward to transforming these connections into long-term collaborations and market-leading products.
Phone: +91 78769 66742, +1 (571)315-3939, +971 52 156 2603
Mail: [email protected]
Location: 1207 Delaware Ave #2877, Wilmington DE 19806, USA
© 2026 OzaBio | All Rights Reserved.
Dynamic Light Scattering (DLS) is employed to evaluate the particle size distribution and polydispersity of liposomal formulations, providing essential information on colloidal stability, dispersion uniformity, and potential bioavailability.
For example – Lipoza®-Curcumin
Caco-2 studies utilize human intestinal epithelial cell monolayers to evaluate the permeability and predicted absorption of test substances across the gut barrier.
For example – Lipoza-Glutathione
Demonstrated superior permeability, showing 0.95% transport compared to 0.29% for Reduced L-Glutathione—an approximate 3.28-fold increase. This enhanced permeability, despite lower glutathione content, indicates improved intestinal absorption and supports its potential as a more bioavailable form of glutathione supplementation.
Fill out the form below and we'll get back to you soon
* indicates required question